Issue brief |

Briefing document on R&D for neglected diseases

Neglected diseases mainly affect people in developing countries. They are the diseases which do not represent a commercially viable market for pharmaceutical companies, because those affected do not have the purchasing power to afford treatment solutions. Companies therefore shirk away from investing into risky and expensive research and development for these conditions.